This finding was later combined with research by Joel Habener and jointly published in JCI.11 The team of Jens Juul Holst at the University of Copenhagen in Denmark published a report in FEBS Letters, reaching the same conclusion in January 1987.23 In December 1987, Stephen Blooms team confirmed in a Lancet paper that GLP-1(7-36) is a human intestinal hormone that stimulates insulin production in the pancreas and lowers blood sugar.24 GLP-1, used for treating diabetes, is quickly broken down in the body, requiring high doses that can cause side effects like nausea
This is perhaps the most exciting emerging area, and well discuss it in detail in upcoming articles
Unlimited online access to articles from across Canada with one account
The peptide stimulates production of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), both essential for follicle health and blood supply to the scalp
"These treatments are a major medical advancement, but too many seniors are currently unable to access them due to high cost," Centers for Medicare & Medicaid Services Administrator Dr